Canagliflozin mitigates increased cardiovascular risk from low-normal sodium intake in type 2 diabetes and CKD
Canagliflozin may protect hearts in patients with low sodium intake
This post hoc analysis of a randomized controlled trial involving 2573 participants with type 2 diabetes and chronic kidney disease found th…
A new analysis suggests the medication canagliflozin helps protect heart health in people with type 2 diabetes and kidney disease who eat le…
Dapagliflozin 10 mg daily maintains consistent diuretic effects regardless of eGFR levels in acute heart failure
Trial Shows Dapagliflozin Works for Heart Failure Across Kidney Ranges
This randomized controlled trial of 238 patients with acute heart failure found that dapagliflozin 10 mg daily did not have its effect on we…
A new trial shows that the heart medication dapagliflozin works consistently for patients with different levels of kidney function.
Continuous intravenous furosemide improves freedom from congestion compared to intermittent bolus administration
Continuous Furosemide May Improve Congestion in Heart Failure Patients
This meta-analysis of 2,633 patients with acute heart failure or NYHA class III-IV symptoms found that continuous intravenous (cIV) furosemi…
A review of clinical data suggests that a continuous infusion of furosemide may help patients with heart failure clear fluid faster than sta…
Demographic and clinical factors associated with poststroke cognitive impairment in stroke patients
Key risk factors identified for cognitive issues after stroke
This meta-analysis examined various risk factors, including age, gender, education level, and comorbidities like hypertension and diabetes, …
New data identifies how age, gender, and underlying conditions like diabetes and high blood pressure impact brain health after a stroke.
Impact of Mitral Prosthesis-Patient Mismatch on Mortality and Outcomes After Valve Replacement
Mitral valve mismatch increases death and hospital risk after surgery
Mitral prosthesis-patient mismatch significantly increases all-cause mortality and heart failure hospitalizations in patients following mitr…
A size mismatch between a heart valve and the patient can lead to more heart failure hospitalizations and higher death rates.
Off-pump CABG reduces mortality risk and stroke risk in patients with left ventricular dysfunction
Off-pump heart surgery shows lower death risk for weak hearts
This meta-analysis of 35,863 patients with multivessel coronary artery disease and left ventricular dysfunction (ejection fraction ≤40%) fou…
A large review of over 35,000 patients suggests off-pump heart surgery may reduce mortality and stroke risks for those with weakened heart m…
Factor XI inhibitors reduce major bleeding but increase ischemic stroke risk in atrial fibrillation
Factor XI inhibitors show lower bleeding risk in atrial fibrillation patients
This meta-analysis of 16852 adults with atrial fibrillation found that Factor XI/XIa inhibitors significantly reduced ISTH major bleeding (O…
A new class of blood thinners may reduce major bleeding risks for people with atrial fibrillation, but they also show higher stroke rates.
Cancer presence associated with OR 1.88 for early mortality following coronary artery bypass grafting
Cancer presence linked to higher risks after heart bypass surgery
This meta-analysis of 99,866 patients underwent coronary artery bypass grafting (CABG) found that the presence of cancer was associated with…
Patients with cancer face higher risks of bleeding and early death following coronary artery bypass grafting procedures.
Catheter ablation reduces serious adverse events and unplanned hospitalizations by 20% and 47% in atrial fibrillation
Catheter Ablation Shows Lower Risk for Atrial Fibrillation Patients
This meta-analysis of randomized trials evaluates catheter ablation versus antiarrhythmic drugs for atrial fibrillation management. The anal…
A meta-analysis of randomized trials suggests catheter ablation may lower risks of serious events and unplanned hospital stays for people wi…
Beta-blocker use associated with lower mortality risk in heart failure with preserved ejection fraction
Beta-Blockers Linked to Lower Mortality in Heart Failure Patients
This meta-analysis of observational studies found that beta-blocker use was associated with lower all-cause and cardiovascular mortality in …
A large study of over 400,000 patients suggests that beta-blocker use is linked to lower death rates for those with a specific type of heart…
Fragmented QRS is associated with a 2.11 risk ratio for post-ablation atrial tachyarrhythmia
Fragmented QRS Signals Linked to Higher Risk After Heart Surgery
This meta-analysis of six cohort studies evaluates the association between fragmented QRS (fQRS) and post-ablation outcomes in patients with…
A specific heart signal called fragmented QRS may help doctors identify patients at higher risk for recurring heart rhythm issues after surg…
Sacubitril/valsartan improves LVEF and NT-proBNP levels in patients with heart failure on peritoneal dialysis
Sacubitril/Valsartan Shows Potential Benefits for Heart Failure Patients
This meta-analysis of 8 observational studies and 1 RCT indicates that sacubitril/valsartan significantly improves LVEF (MD 5.22) and reduce…
New data suggests sacubitril/valsartan may improve heart function and lower blood pressure in patients with heart failure on peritoneal dial…